You just read:

Advanced Practice Providers Treat Significantly More of their Multiple Sclerosis Patients with Monoclonal Antibody Disease-Modifying Therapies Compared to Neurologists in the US

News provided by

Spherix Global Insights

Nov 15, 2017, 10:14 ET